New cure strategies for Hepatitis B are in development. Emerging data suggests a key role for biomarkers to identify subsets of people living with Hepatitis B who are most likely to respond to treatment. In this webinar, we discussed recent advances in Hepatitis B biomarker development, and how these tools can be used to personalise the management of people living with Hepatitis B.
Is Hepatitis B entering the era of personalised medicine?
April 18, 2023
Article
Get subscribe to LabInsights latest news and update

Get subscribe to Lab Insights latest news and update

More on same topic
Select a related post from the options below.
Next Read